Portefeuille d'ETF SCHB (NYSE) - Page 103 | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

CATX Perspective Therapeutics Inc 337.8456 K 62.5640 K 0.0009%

OFIX Orthofix Medical Inc 337.4111 K 24.9380 K 0.0009%

SIBN SI-BONE Inc 337.1410 K 21.7230 K 0.0009%

ALRS Alerus Financial Corp 336.5731 K 14.1180 K 0.0009%

SEPN Septerna Inc 336.0516 K 11.5800 K 0.0009%

Hingham Institution For Savings The 334.9440 K 1 200.0000 0.0009%

AROW Arrow Financial Corp 331.9675 K 9 966.0000 0.0009%

PRAA PRA Group Inc 330.1358 K 20.9610 K 0.0009%

RDVT Red Violet Inc 330.0222 K 7 620.0000 0.0009%

SMBK SmartFinancial Inc 328.1877 K 8 370.0000 0.0008%

RBCAA Republic Bancorp Inc/KY 328.1640 K 4 756.0000 0.0008%

MBUU Malibu Boats Inc 325.9660 K 11.2170 K 0.0008%

AHRT Armada Hoffler Properties Inc 324.3250 K 51.8920 K 0.0008%

CLBK Columbia Financial Inc 322.9160 K 18.0400 K 0.0008%

AVO Mission Produce Inc 322.4819 K 22.7260 K 0.0008%

HTZ Hertz Global Holdings Inc 321.8724 K 70.8970 K 0.0008%

S

SEMR SEMrush Holdings Inc 321.7877 K 27.2240 K 0.0008%

BDN Brandywine Realty Trust 320.0208 K 100.3200 K 0.0008%

BETA Beta Technologies Inc 319.6000 K 17.0000 K 0.0008%

MDXG MiMedx Group Inc 318.8035 K 65.1950 K 0.0008%

Nouvelles

SCHB: SCHB: A Hold Amid Premium Valuations And Higher Risk-Free Rates (NYSEARCA:SCHB)

Large Caps - Big Opportunity

3 Reasons Why I Remain Bullish On SCHB, And 2 To Sell It Immediately (NYSEARCA:SCHB)

Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019

Big Tech's $635B AI Push Meets Energy Crunch: ETFs to Diversify

Patience Pays: ETFs You Can Buy and Hold for the Long Run

3 Best ETFs to Invest In, According to AI Analyst, 2/5/2026 - TipRanks.com

SCHB: The Conflict Between Short- And Long-Term Risks (NYSEARCA:SCHB)

ETFs to Keep Your Portfolio on Track in the Long Term

SCHB: Core Equity Holding For Diversified Investors (NYSEARCA:SCHB)

Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope

Equity Outlook: From Caution To Complacency?